A recent Food and Drug Administration public meeting kicked off a two-month comment period during which stakeholders have been encouraged to share their input on how best to improve generic competition and what current barriers exist.
Walgreens' Center for Health & Wellbeing Research is led by a team of more than 25 Walgreens health services researchers, clinicians, statisticians, public health practitioners, actuaries and data scientists.
National Association of Chain Drug Stores president and CEO Steve Anderson said that NACDS' comments shared with the President’s Commission on Combating Drug Addiction and the Opioid Crisis were discussed in the meeting.
NACDS president and CEO Steve Anderson weighs in on the continued work necessary to combat the opioid crisis following the preliminary report of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
At a public meeting on July 18, Food and Drug Administration commissioner Scott Gottlieb said that by the end of the year, the agency would develop an internal strategy for dealing with abbreviated new drug applications, as well as a guidance on the best submission practices.
Jean Coutu founder Jean Coutu spoke out regarding negotiations with Quebec around dispensing fees, according to a report published last week by Canada's Bell Media. Jean Coutu earlier this year agreed to surrender $300 million in collected dispensing fees in return for smaller manufacturer rebates that cut into pharmacy operating margins. "It is an average of $100,000 for each of our locations," Coutu told shareholders BellMedia reported. "It was extremely difficult to digest." (Bell Media)
The pilot, included in the 2017 federal budget plan, would allow TRICARE beneficiaries to get their prescriptions from retail pharmacies, rather than by mail order or through military treatment facilities.